Palli D

No ORCID on file · 4 papers in corpus
2019
Development and validation of circulating CA125 prediction models in postmenopausal women.
Journal of ovarian research ·doi:10.1186/s13048-019-0591-4

BackgroundCancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal charac…

review 2019
The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis
Critical reviews in oncology/hematology ·doi:10.1016/j.critrevonc.2018.12.009

We conducted a meta-analysis of studies reporting on the risk of extra-ovarian malignancies among women with endometriosis. Summary relative risk (SRR) and 95% confidence intervals (CI) were calculated through random effect models. We explo…

2017
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.
British journal of cancer ·doi:10.1038/bjc.2017.299

BackgroundThe Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone in…

2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature genetics ·doi:10.1038/ng.3826

To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptib…